124 related articles for article (PubMed ID: 10950791)
1. CD8+ cytotoxic T lymphocyte responses to lytic proteins of human herpes virus 8 in human immunodeficiency virus type 1-infected and -uninfected individuals.
Wang QJ; Jenkins FJ; Jacobson LP; Meng YX; Pellett PE; Kingsley LA; Kousoulas KG; Baghian A; Rinaldo CR
J Infect Dis; 2000 Sep; 182(3):928-32. PubMed ID: 10950791
[TBL] [Abstract][Full Text] [Related]
2. Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteins.
Wang QJ; Jenkins FJ; Jacobson LP; Kingsley LA; Day RD; Zhang ZW; Meng YX; Pellett PE; Kousoulas KG; Baghian A; Rinaldo CR
Blood; 2001 Apr; 97(8):2366-73. PubMed ID: 11290599
[TBL] [Abstract][Full Text] [Related]
3. Identification of human herpesvirus 8-specific cytotoxic T-cell responses.
Osman M; Kubo T; Gill J; Neipel F; Becker M; Smith G; Weiss R; Gazzard B; Boshoff C; Gotch F
J Virol; 1999 Jul; 73(7):6136-40. PubMed ID: 10364372
[TBL] [Abstract][Full Text] [Related]
4. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
[TBL] [Abstract][Full Text] [Related]
5. Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8.
Micheletti F; Monini P; Fortini C; Rimessi P; Bazzaro M; Andreoni M; Giuliani M; Traniello S; Ensoli B; Gavioli R
Immunology; 2002 Jul; 106(3):395-403. PubMed ID: 12100728
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women.
Kedes DH; Ganem D; Ameli N; Bacchetti P; Greenblatt R
JAMA; 1997 Feb; 277(6):478-81. PubMed ID: 9020272
[TBL] [Abstract][Full Text] [Related]
7. Identification of CD8+ T cell epitopes within lytic antigens of human herpes virus 8.
Ribechini E; Fortini C; Marastoni M; Traniello S; Spisani S; Monini P; Gavioli R
J Immunol; 2006 Jan; 176(2):923-30. PubMed ID: 16393977
[TBL] [Abstract][Full Text] [Related]
8. Ex-vivo recognition of late-lytic CD8 epitopes specific for Kaposi's sarcoma-associated herpesvirus (KSHV) by HIV/KSHV-coinfected individuals.
Robey RC; Mletzko S; Bower M; Meys R; Boffito M; Nelson M; Bunker CB; Gotch FM
Viral Immunol; 2011 Jun; 24(3):211-20. PubMed ID: 21668362
[TBL] [Abstract][Full Text] [Related]
9. Identification of an HLA A*0201-restricted CD8(+) T-cell epitope for the glycoprotein B homolog of human herpesvirus 8.
Wang QJ; Huang XL; Rappocciolo G; Jenkins FJ; Hildebrand WH; Fan Z; Thomas EK; Rinaldo CR
Blood; 2002 May; 99(9):3360-6. PubMed ID: 11964304
[TBL] [Abstract][Full Text] [Related]
10. Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma.
Guihot A; Dupin N; Marcelin AG; Gorin I; Bedin AS; Bossi P; Galicier L; Oksenhendler E; Autran B; Carcelain G
J Infect Dis; 2006 Oct; 194(8):1078-88. PubMed ID: 16991082
[TBL] [Abstract][Full Text] [Related]
11. Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapy.
Wilkinson J; Cope A; Gill J; Bourboulia D; Hayes P; Imami N; Kubo T; Marcelin A; Calvez V; Weiss R; Gazzard B; Boshoff C; Gotch F
J Virol; 2002 Mar; 76(6):2634-40. PubMed ID: 11861829
[TBL] [Abstract][Full Text] [Related]
12. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.
Renwick N; Halaby T; Weverling GJ; Dukers NH; Simpson GR; Coutinho RA; Lange JM; Schulz TF; Goudsmit J
AIDS; 1998 Dec; 12(18):2481-8. PubMed ID: 9875587
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T Cell Effect on CD8
Lepone LM; Rappocciolo G; Piazza PA; Campbell DM; Jenkins FJ; Rinaldo CR
AIDS Res Hum Retroviruses; 2017 Jul; 33(7):668-674. PubMed ID: 28121161
[TBL] [Abstract][Full Text] [Related]
14. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T lymphocyte responses to vaccinia virus antigens but not HIV-1 subtype E envelope protein seen in HIV-1 seronegative Thais.
Kantakamalakul W; Cox J; Kositanont U; Siritantikorn S; Limbach K; Birx D; Thongcharoen P; Puthavathana P
Asian Pac J Allergy Immunol; 2001 Mar; 19(1):17-22. PubMed ID: 11495295
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.
Newton R; Carpenter L; Casabonne D; Beral V; Babiker A; Darbyshire J; Weller I; Weiss R; Kwan A; Bourboulia D; Munoz F; Lagos D; Boshoff C
Br J Cancer; 2006 May; 94(10):1504-9. PubMed ID: 16705315
[TBL] [Abstract][Full Text] [Related]
17. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
Wilson SE; Pedersen SL; Kunich JC; Wilkins VL; Mann DL; Mazzara GP; Tartaglia J; Celum CL; Sheppard HW
AIDS Res Hum Retroviruses; 1998 Jul; 14(11):925-37. PubMed ID: 9686639
[TBL] [Abstract][Full Text] [Related]
18. Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens.
Tigges MA; Koelle D; Hartog K; Sekulovich RE; Corey L; Burke RL
J Virol; 1992 Mar; 66(3):1622-34. PubMed ID: 1310769
[TBL] [Abstract][Full Text] [Related]
19. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
[TBL] [Abstract][Full Text] [Related]
20. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
